Jiangsu Hengrui Medicine
600276.SS
#505
Rank
C$58.48 B
Marketcap
$9.17
Share price
0.30%
Change (1 day)
6.55%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Net assets

Net assets on the balance sheet as of September 2024 : C$9.05 Billion

According to Jiangsu Hengrui Medicine 's latest financial reports the company has C$9.05 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Jiangsu Hengrui Medicine - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2022-12-31$C$7.55 B6.23%
2021-12-31$C$7.11 B18.2%
2020-12-31$C$6.01 B29.09%
2019-12-31$C$4.66 B18.13%
2018-12-31$C$3.94 B28.1%
2017-12-31$C$3.08 B23.66%
2016-12-31$C$2.49 B12.39%
2015-12-31$C$2.21 B45.07%
2014-12-31$C$1.52 B30.53%
2013-12-31$C$1.17 B34.87%
2012-12-31$C$0.86 B22.49%
2011-12-31$C$0.70 B34.91%
2010-12-31$C$0.52 B27.95%
2009-12-31$C$0.41 B13.63%
2008-12-31$C$0.36 B59.58%
2007-12-31$C$0.22 B19.76%
2006-12-31$C$0.18 B18.22%
2005-12-31$C$0.15 B10.27%
2004-12-31$C$0.14 B2.3%
2003-12-31$C$0.14 B-8.29%
2002-12-31$C$0.15 B5.94%
2001-12-31$C$0.14 B